Study S000449

A Single-dose, Open-label/Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06132204
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 16
Start: 2023-12-21
Primary completion: 2024-03-13
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:HRS-7535 Tablets
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

PK parameters of HRS-7535: Cmax [0 hour to 48 hour after administration]
PK parameters of HRS-7535: AUC0-t [0 hour to 48 hour after administration]
PK parameters of HRS-7535: AUC0-inf [0 hour to Infinity hour after administration]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.